Категории

Economic Burden of Cardiovascular Disease

Опубликовано: 10 Июль 2020
на канале: AJMCtv
225
2

Eric Cannon, PharmD, FAMCP, highlights the main drivers that contribute to the economic burden of cardiovascular disease.

Смотрите видео Economic Burden of Cardiovascular Disease онлайн, длительностью часов минут секунд в хорошем качестве, которое загружено на канал AJMCtv 10 Июль 2020. Делитесь ссылкой на видео в социальных сетях, чтобы ваши подписчики и друзья так же посмотрели это видео. Данный видеоклип посмотрели 225 раз и оно понравилось 2 посетителям.

play_arrow
133,065
786

Карело-финская полька - cover by Артур Пикалов

Карело-финская полька - cover by Артур Пикалов
play_arrow
303,626
26 тыс

SE INSCREVE AI POXA 🥲🥰😂

SE INSCREVE AI POXA 🥲🥰😂

play_arrow
55
0

Fuhla Tutorial - Overview

Fuhla Tutorial - Overview
play_arrow
200
6

Сын Мавроди

Сын Мавроди

play_arrow
211
3

Tamayo Perry makes it rain

Tamayo Perry makes it rain
play_arrow
2,447
192

Stepn | ЧТО БУДЕТ ДАЛЬШЕ | МОЙ ПЛАН ДЕЙСТВИЙ| КУРС GST, ФЛОР

Stepn | ЧТО БУДЕТ ДАЛЬШЕ | МОЙ ПЛАН ДЕЙСТВИЙ| КУРС GST, ФЛОР
play_arrow
212
22

THE BEST FUNKO POPS OF 2021?

THE BEST FUNKO POPS OF 2021?
play_arrow
1,306
3

sliv private soft standoff 2

sliv private soft standoff 2
Похожие видео
play_arrow
Dr Mark Fendrick Explains Bipartisan Appeal of Value-Based Insurance Design

Dr Mark Fendrick Explains Bipartisan Appeal of Value-Based Insurance Design
play_arrow
Dr Frank Porreca Talks Through the Challenges of Measuring Migraine Pain

Dr Frank Porreca Talks Through the Challenges of Measuring Migraine Pain
play_arrow
Dr Peter McAllister Shares How COVID-19 Altered Patients' Migraine Symptoms

Dr Peter McAllister Shares How COVID-19 Altered Patients' Migraine Symptoms
play_arrow
Dr Stephen Silberstein Discusses Erenumab Use for Menstrual Migraine

Dr Stephen Silberstein Discusses Erenumab Use for Menstrual Migraine
play_arrow
Dr Ruth Ann Marrie Discusses Comorbidities in Multiple Sclerosis

Dr Ruth Ann Marrie Discusses Comorbidities in Multiple Sclerosis
play_arrow
Dr George Bakris Compares FIDELIO-DKD Renal Outcomes With Those of SGLT-2 Inhibitor Trials

Dr George Bakris Compares FIDELIO-DKD Renal Outcomes With Those of SGLT-2 Inhibitor Trials
play_arrow
Dr Shweta Bansal Explains Factors Associated With Increased Screening, Recognition of CKD

Dr Shweta Bansal Explains Factors Associated With Increased Screening, Recognition of CKD
play_arrow
Dr Joshua Rein Offers Insights on Cannabis Use for Chronic Kidney Disease

Dr Joshua Rein Offers Insights on Cannabis Use for Chronic Kidney Disease
play_arrow
Akebia Therapeutics' CEO on Mechanisms of HIF-PHI Candidate

Akebia Therapeutics' CEO on Mechanisms of HIF-PHI Candidate
play_arrow
Dr Rajiv Agarwal Discusses Finerenone, Results of FIDELIO-DKD

Dr Rajiv Agarwal Discusses Finerenone, Results of FIDELIO-DKD
play_arrow
Dr Timothy Yap Reiterates the Unmet Medical Need for Molecularly Targeted Agents in Solid Tumors

Dr Timothy Yap Reiterates the Unmet Medical Need for Molecularly Targeted Agents in Solid Tumors
play_arrow
Whole-Person Health Care: Integrating Mental and Behavioral Health Into Primary Care

Whole-Person Health Care: Integrating Mental and Behavioral Health Into Primary Care
play_arrow
A Patient Perspective on Early-Onset Parkinson Disease

A Patient Perspective on Early-Onset Parkinson Disease
play_arrow
Dr Stephen Silberstein Compares the Effects of Erenumab on Chronic, Episodic Migraine

Dr Stephen Silberstein Compares the Effects of Erenumab on Chronic, Episodic Migraine
play_arrow
Dr Frank Porreca Discusses New Developments in Migraine Science

Dr Frank Porreca Discusses New Developments in Migraine Science
play_arrow
Dr Andre Goy Discusses What We’ve Learned About CAR T Therapies and Cytokine Responses

Dr Andre Goy Discusses What We’ve Learned About CAR T Therapies and Cytokine Responses
play_arrow
Dr Neal Jain Discusses Type 2 Inflammation in Asthma

Dr Neal Jain Discusses Type 2 Inflammation in Asthma
play_arrow
Dr Kassandra Munger on Vitamin D and Multiple Sclerosis

Dr Kassandra Munger on Vitamin D and Multiple Sclerosis
play_arrow
Dr Timothy Yap: Rucaparib/Sacituzumab Govitecan Combo Effective Against Triple-Negative Disease

Dr Timothy Yap: Rucaparib/Sacituzumab Govitecan Combo Effective Against Triple-Negative Disease
play_arrow
Dr Neal Jain on the Real-World Results of Dupilumab in Asthma

Dr Neal Jain on the Real-World Results of Dupilumab in Asthma
play_arrow
Using SGLT2 Inhibitors to Achieve Cardiovascular Benefits

Using SGLT2 Inhibitors to Achieve Cardiovascular Benefits
play_arrow
Dr Melissa Johnson: Tiragolumab/Atezolizumab Potential New Treatment Option for NSCLC

Dr Melissa Johnson: Tiragolumab/Atezolizumab Potential New Treatment Option for NSCLC
play_arrow
Cost-Effectiveness Data and Pricing of Icosapent Ethyl

Cost-Effectiveness Data and Pricing of Icosapent Ethyl
play_arrow
Dr John McMurray Compares EMPEROR-Reduced Findings with DAPA-HF

Dr John McMurray Compares EMPEROR-Reduced Findings with DAPA-HF